v3.22.2.2
CONDENSED INTERIM STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
OPERATING EXPENSES        
Research and Development $ 1,591,043 $ 1,126,972 $ 3,321,623 $ 1,313,954
General and Administrative 1,950,551 3,515,250 5,510,642 8,873,160
TOTAL OPERATING EXPENSES 3,541,594 4,642,222 8,832,265 10,187,114
Gain on Forgiveness of Paycheck Protection Program Loan       66,503
NET LOSS $ (3,541,594) $ (4,642,222) $ (8,832,265) $ (10,120,611)
LOSS PER SHARE        
Basic net loss per common share/units $ (0.32) $ (0.46) $ (0.84) $ (1.27)
Diluted net loss per common share/units $ (0.32) $ (0.46) $ (0.84) $ (1.27)
Weighted average common shares/units outstanding basic 11,148,402 10,116,403 10,551,503 7,988,563
Weighted average common shares/units outstanding diluted 11,148,402 10,116,403 10,551,503 7,988,563

Source